Variant report

Variant	esv3430577
Chromosome Location	chr19:42247653-42285973
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:884)
CpG islands
(count:427)
Chromatin interactive
region (count:69)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:884 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr19:42257990-42258186	GM12878	blood:	n/a	n/a
2	BHLHE40	chr19:42257236-42257273	A549	lung:	n/a	n/a
3	BRCA1	chr19:42250661-42250845	Hela-S3	cervix:	n/a	n/a
4	CBX3	chr19:42278204-42278885	HCT-116	colon:	n/a	n/a
5	CEBPB	chr19:42258041-42258115	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr19:42258033-42258079	K562	blood:	n/a	n/a
7	CEBPB	chr19:42278147-42278921	HCT-116	colon:	n/a	n/a
8	CEBPB	chr19:42258453-42258801	MCF-7	breast:	n/a	n/a
9	CEBPB	chr19:42278385-42278849	MCF-7	breast:	n/a	n/a
10	CEBPB	chr19:42258406-42258941	MCF-7	breast:	n/a	n/a
11	CEBPB	chr19:42278289-42278831	MCF-7	breast:	n/a	n/a
12	CTCF	chr19:42250640-42250790	HPAF	blood vessel:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
13	CTCF	chr19:42257126-42257371	LNCaP	prostate:	n/a	chr19:42257276-42257294 chr19:42257278-42257299 chr19:42257279-42257292 chr19:42257279-42257288 chr19:42257281-42257291 chr19:42257279-42257292 chr19:42257277-42257293
14	CTCF	chr19:42258620-42258770	GM12872	blood:	n/a	n/a
15	CTCF	chr19:42250640-42250790	NHDF-neo	bronchial:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
16	CTCF	chr19:42257867-42258170	SK-N-SH_RA	brain:	n/a	n/a
17	CTCF	chr19:42250620-42250770	AG10803	skin:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
18	CTCF	chr19:42257878-42258159	GM12892	blood:	n/a	n/a
19	CTCF	chr19:42257052-42257438	K562	blood:	n/a	chr19:42257276-42257294 chr19:42257278-42257299 chr19:42257279-42257292 chr19:42257279-42257288 chr19:42257281-42257291 chr19:42257279-42257292 chr19:42257277-42257293
20	CTCF	chr19:42257920-42258070	HUVEC	blood vessel:	n/a	n/a
21	CTCF	chr19:42257679-42257756	GM12891	blood:	n/a	n/a
22	CTCF	chr19:42257920-42258070	GM12875	blood:	n/a	n/a
23	CTCF	chr19:42252318-42252383	LNCaP	prostate:	n/a	n/a
24	CTCF	chr19:42258540-42258690	HCPEpiC	choroid plexus:	n/a	n/a
25	CTCF	chr19:42256605-42256651	GM12892	blood:	n/a	n/a
26	CTCF	chr19:42250660-42250810	AG10803	skin:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
27	CTCF	chr19:42257840-42257990	HFF-Myc	foreskin:	n/a	n/a
28	CTCF	chr19:42250680-42250830	HVMF	connective:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
29	CTCF	chr19:42250640-42250790	GM12872	blood:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
30	CTCF	chr19:42257240-42257390	SAEC	small airway:	n/a	chr19:42257276-42257294 chr19:42257278-42257299 chr19:42257279-42257292 chr19:42257279-42257288 chr19:42257281-42257291 chr19:42257279-42257292 chr19:42257277-42257293
31	CTCF	chr19:42257180-42257350	SK-N-SH_RA	brain:	n/a	chr19:42257276-42257294 chr19:42257278-42257299 chr19:42257279-42257292 chr19:42257279-42257288 chr19:42257281-42257291 chr19:42257279-42257292 chr19:42257277-42257293
32	CTCF	chr19:42256953-42257061	GM19240	blood:	n/a	n/a
33	CTCF	chr19:42257940-42258090	GM12870	blood:	n/a	n/a
34	CTCF	chr19:42257200-42257350	HVMF	connective:	n/a	chr19:42257276-42257294 chr19:42257278-42257299 chr19:42257279-42257292 chr19:42257279-42257288 chr19:42257281-42257291 chr19:42257279-42257292 chr19:42257277-42257293
35	CTCF	chr19:42250640-42250790	Caco-2	colon:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
36	CTCF	chr19:42250680-42250830	GM12878	blood:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
37	CTCF	chr19:42250120-42250270	GM06990	blood:	n/a	n/a
38	CTCF	chr19:42251360-42251510	HEK293	kidney:	n/a	n/a
39	CTCF	chr19:42257920-42258070	HA-sp	spinal cord:	n/a	n/a
40	CTCF	chr19:42257904-42258203	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr19:42250660-42250810	SK-N-SH_RA	brain:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
42	CTCF	chr19:42257940-42258090	HFF-Myc	foreskin:	n/a	n/a
43	CTCF	chr19:42256440-42256590	GM12865	blood:	n/a	n/a
44	CTCF	chr19:42250680-42250830	NHDF-neo	bronchial:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
45	CTCF	chr19:42250640-42250790	GM12866	blood:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
46	CTCF	chr19:42257140-42257290	HCT-116	colon:	n/a	chr19:42257279-42257288
47	CTCF	chr19:42257506-42257619	GM12892	blood:	n/a	n/a
48	CTCF	chr19:42250640-42250790	HBMEC	blood vessel:	n/a	chr19:42250724-42250742 chr19:42250719-42250740
49	CTCF	chr19:42257900-42258050	BJ	skin:	n/a	n/a
50	CTCF	chr19:42250638-42250886	GM19239	blood:	n/a	chr19:42250724-42250742 chr19:42250719-42250740

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42259235-42259285	NT2-D1	testis:	n/a
2	chr19:42274924-42274974	Hela-S3	cervix:	n/a
3	chr19:42258336-42258386	HEEpiC	esophagus:	n/a
4	chr19:42260485-42260535	NT2-D1	testis:	n/a
5	chr19:42275193-42275243	AG04449	skin:	fetal
6	chr19:42259235-42259285	NHBE	bronchial:	n/a
7	chr19:42275193-42275243	PANC-1	pancreas:	n/a
8	chr19:42259081-42259131	Caco-2	colon:	n/a
9	chr19:42259235-42259285	ProgFib	skin:	n/a
10	chr19:42275193-42275243	NHDF-neo	bronchial:	n/a
11	chr19:42259235-42259285	BE2_C	brain:	n/a
12	chr19:42258336-42258386	PrEC	prostate:	n/a
13	chr19:42274924-42274974	HEEpiC	esophagus:	n/a
14	chr19:42259081-42259131	NT2-D1	testis:	n/a
15	chr19:42260485-42260535	BE2_C	brain:	n/a
16	chr19:42274924-42274974	HCM	heart:	n/a
17	chr19:42260485-42260535	ProgFib	skin:	n/a
18	chr19:42258336-42258386	IMR90	lung:	fetal
19	chr19:42258336-42258386	GM12891	blood:	n/a
20	chr19:42259235-42259285	ovcar-3	ovarian:	n/a
21	chr19:42260485-42260535	T-47D	breast:	n/a
22	chr19:42274924-42274974	AoSMC	blood vessel:	n/a
23	chr19:42260485-42260535	NHDF-neo	bronchial:	n/a
24	chr19:42259235-42259285	GM12878	blood:	n/a
25	chr19:42275193-42275243	A549	lung:	n/a
26	chr19:42275193-42275243	HUVEC	blood vessel:	n/a
27	chr19:42275193-42275243	U87	brain:	n/a
28	chr19:42259395-42259445	GM12892	blood:	n/a
29	chr19:42259235-42259285	NH-A	brain:	n/a
30	chr19:42275193-42275243	GM12878	blood:	n/a
31	chr19:42260485-42260535	AG04450	lung:	fetal
32	chr19:42274924-42274974	HCPEpiC	choroid plexus:	n/a
33	chr19:42259395-42259445	HUVEC	blood vessel:	n/a
34	chr19:42275193-42275243	HMEC	breast:	n/a
35	chr19:42259081-42259131	HPAEpiC	pulmonary alveolar:	n/a
36	chr19:42260485-42260535	AG09319	gingival:	n/a
37	chr19:42274924-42274974	AG04449	skin:	fetal
38	chr19:42275193-42275243	HRE	kidney:	n/a
39	chr19:42258336-42258386	HRE	kidney:	n/a
40	chr19:42259081-42259131	HEEpiC	esophagus:	n/a
41	chr19:42259081-42259131	HepG2	liver:	n/a
42	chr19:42274924-42274974	MCF10A-Er-Src	breast:	n/a
43	chr19:42259081-42259131	NHBE	bronchial:	n/a
44	chr19:42274924-42274974	GM06990	blood:	n/a
45	chr19:42259081-42259131	PrEC	prostate:	n/a
46	chr19:42259235-42259285	PFSK-1	brain:	n/a
47	chr19:42274924-42274974	HepG2	liver:	n/a
48	chr19:42259081-42259131	BJ	skin:	n/a
49	chr19:42258336-42258386	HepG2	liver:	n/a
50	chr19:42275193-42275243	HIPEpiC	eye:	n/a

(count:69 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr19:42256392..42258478-chr19:42289082..42290564,19	MCF-7	breast:
2	chr19:42278093..42278816-chr19:42296664..42297371,2	MCF-7	breast:
3	chr19:42261241..42262900-chr19:42275127..42276730,2	MCF-7	breast:
4	chr19:42261241..42262900-chr19:42275127..42276730,2	MCF-7	breast:
5	chr19:42257939..42260578-chr19:42260800..42262480,2	K562	blood:
6	chr19:42211491..42212027-chr19:42250292..42251139,2	K562	blood:
7	chr19:42250343..42251080-chr19:42288592..42289100,2	MCF-7	breast:
8	chr19:42258418..42261395-chr19:42263333..42266210,2	K562	blood:
9	chr19:42256872..42257731-chr19:42277925..42278830,2	MCF-7	breast:
10	chr19:42238849..42240375-chr19:42277307..42280132,2	MCF-7	breast:
11	chr19:42210648..42213513-chr19:42249142..42252570,4	MCF-7	breast:
12	chr19:42210268..42210769-chr19:42257717..42258347,2	MCF-7	breast:
13	chr19:42256878..42257460-chr19:42288323..42288994,2	MCF-7	breast:
14	chr19:42214835..42216861-chr19:42256777..42258757,2	MCF-7	breast:
15	chr19:42210733..42211670-chr19:42256878..42258361,4	K562	blood:
16	chr19:42238634..42240225-chr19:42250463..42251967,2	MCF-7	breast:
17	chr19:42212037..42212962-chr19:42250295..42251188,4	MCF-7	breast:
18	chr19:42208175..42212316-chr19:42277076..42281781,5	MCF-7	breast:
19	chr19:42278941..42284055-chr19:42287718..42293319,7	MCF-7	breast:
20	chr19:42271676..42273430-chr19:42276461..42278418,2	MCF-7	breast:
21	chr19:42210030..42211723-chr19:42249785..42251642,16	MCF-7	breast:
22	chr19:42148303..42148992-chr19:42250108..42251260,4	K562	blood:
23	chr19:42254797..42261680-chr19:42284783..42292674,12	MCF-7	breast:
24	chr19:42146223..42148129-chr19:42277106..42278816,2	MCF-7	breast:
25	chr19:42250749..42252304-chr19:42286973..42289582,3	MCF-7	breast:
26	chr19:42284065..42287581-chr19:42289073..42291292,3	MCF-7	breast:
27	chr19:42147964..42148906-chr19:42250000..42251190,4	MCF-7	breast:
28	chr19:42258691..42261541-chr19:42266017..42268400,4	MCF-7	breast:
29	chr19:42252204..42254602-chr19:42292364..42294329,2	MCF-7	breast:
30	chr19:42264279..42265864-chr19:42267759..42270746,2	MCF-7	breast:
31	chr19:42252191..42260165-chr19:42275924..42285275,20	MCF-7	breast:
32	chr19:42278432..42280724-chr19:42363610..42365234,2	MCF-7	breast:
33	chr19:42147220..42149633-chr19:42250736..42252324,3	MCF-7	breast:
34	chr19:42280334..42281890-chr19:42288112..42290516,2	MCF-7	breast:
35	chr19:42253269..42255875-chr19:42299289..42301420,2	MCF-7	breast:
36	chr19:42210407..42210988-chr19:42249087..42249617,2	MCF-7	breast:
37	chr19:42249789..42252137-chr19:42296229..42297905,2	MCF-7	breast:
38	chr19:42281683..42284072-chr19:42363148..42365714,2	MCF-7	breast:
39	chr19:42267949..42271165-chr19:42271348..42273565,4	MCF-7	breast:
40	chr19:42256322..42257851-chr19:42324890..42325806,7	K562	blood:
41	chr19:42255651..42257648-chr19:42288124..42290756,2	MCF-7	breast:
42	chr19:42259394..42260982-chr19:42261477..42263046,2	MCF-7	breast:
43	chr19:42254797..42261680-chr19:42284783..42292674,12	MCF-7	breast:
44	chr19:42210533..42211382-chr19:42250275..42251260,3	K562	blood:
45	chr19:42270435..42273069-chr19:42278370..42280159,2	MCF-7	breast:
46	chr19:42283769..42285761-chr19:42286969..42288964,2	MCF-7	breast:
47	chr19:42259424..42262726-chr19:42264710..42268289,4	K562	blood:
48	chr19:42256872..42257731-chr19:42277925..42278830,2	MCF-7	breast:
49	chr19:42267949..42271165-chr19:42271348..42273565,4	MCF-7	breast:
50	chr19:42271676..42273430-chr19:42276461..42278418,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LYPD4-3	chr19:42261806-42261989	ENSG00000268833.1

No data

Variant related genes	Relation type
CEACAM6	TF binding region
CEACAM6	CpG island
ENSG00000170956	chromatin interactions
ENSG00000269354	chromatin interactions
ENSG00000105388	chromatin interactions
ENSG00000267881	chromatin interactions
ENSG00000007306	chromatin interactions
ENSG00000268833	chromatin interactions
ENSG00000086548	chromatin interactions
ENSG00000105372	chromatin interactions
ENSG00000168564	chromatin interactions

Extended variants
information (count: 1570 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:1570 , 50 per page) page: 1 2 3 4 5 6 7 ... 32

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs386809394	chr19:42247666-42247667	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs73932056	chr19:42247667-42247668	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs372362293	chr19:42247670-42247671	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs73932057	chr19:42247685-42247686	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs532689082	chr19:42247710-42247711	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs145724818	chr19:42247737-42247738	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs368573732	chr19:42247740-42247741	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs142369052	chr19:42247794-42247795	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs565989369	chr19:42247797-42247798	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs151268675	chr19:42247807-42247808	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs140534868	chr19:42247854-42247855	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs145617041	chr19:42247933-42247934	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs536866472	chr19:42247944-42247945	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs146517849	chr19:42247964-42247965	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs186333889	chr19:42248030-42248031	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs115453208	chr19:42248038-42248039	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs188213959	chr19:42248071-42248072	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs563856254	chr19:42248133-42248134	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs574353098	chr19:42248137-42248138	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs543272419	chr19:42248152-42248153	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs748249	chr19:42248208-42248209	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs180736458	chr19:42248248-42248249	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs376535557	chr19:42248298-42248299	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs367945267	chr19:42248332-42248333	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs141163188	chr19:42248333-42248334	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs577267069	chr19:42248345-42248346	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs150164378	chr19:42248362-42248363	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs376582291	chr19:42248383-42248384	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs559661600	chr19:42248428-42248429	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs6508994	chr19:42248429-42248430	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs548050168	chr19:42248437-42248438	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs372103761	chr19:42248457-42248458	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs530747312	chr19:42248459-42248460	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs551943240	chr19:42248519-42248520	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs112384131	chr19:42248599-42248600	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs141802087	chr19:42248600-42248601	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs386809395	chr19:42248601-42248602	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs200683933	chr19:42248603-42248604	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs150584506	chr19:42248611-42248612	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs62117365	chr19:42248626-42248627	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs149291214	chr19:42248651-42248652	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs546393486	chr19:42248657-42248658	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs201663012	chr19:42248659-42248660	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs568021737	chr19:42248694-42248695	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs529214864	chr19:42248704-42248705	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs143508751	chr19:42248714-42248715	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs185020628	chr19:42248726-42248727	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs191048326	chr19:42248781-42248782	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs34810102	chr19:42248796-42248797	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs537790956	chr19:42248807-42248808	Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:340 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:42240400-42249600	Weak transcription	Duodenum Mucosa	Duodenum
2	chr19:42243400-42247800	Enhancers	Rectal Mucosa Donor 31	rectum
3	chr19:42245000-42248000	Weak transcription	Sigmoid Colon	Sigmoid Colon
4	chr19:42245800-42248000	Weak transcription	Fetal Intestine Large	intestine
5	chr19:42245800-42248200	Weak transcription	Fetal Intestine Small	intestine
6	chr19:42246200-42248400	Enhancers	Primary neutrophils fromperipheralblood	blood
7	chr19:42246600-42250600	Enhancers	Monocytes-CD14+_RO01746	blood
8	chr19:42246600-42250800	Enhancers	Primary monocytes fromperipheralblood	blood
9	chr19:42246600-42251000	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr19:42247000-42248400	Enhancers	Colonic Mucosa	Colon
11	chr19:42247000-42248600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr19:42247000-42249000	Weak transcription	Stomach Mucosa	stomach
13	chr19:42247000-42249600	Enhancers	Primary B cells from cord blood	blood
14	chr19:42247000-42251000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr19:42247200-42249000	Enhancers	Primary hematopoietic stem cells	blood
16	chr19:42247800-42248000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
17	chr19:42247800-42249200	Enhancers	Rectal Mucosa Donor 29	rectum
18	chr19:42248000-42248200	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr19:42248000-42249000	Enhancers	Primary B cells from peripheral blood	blood
20	chr19:42248000-42249400	Enhancers	Sigmoid Colon	Sigmoid Colon
21	chr19:42248000-42250600	Enhancers	Fetal Intestine Large	intestine
22	chr19:42248200-42248400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
23	chr19:42248200-42251000	Enhancers	Fetal Intestine Small	intestine
24	chr19:42248400-42249000	Weak transcription	Colonic Mucosa	Colon
25	chr19:42248400-42250800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
26	chr19:42248400-42250800	Enhancers	Rectal Mucosa Donor 31	rectum
27	chr19:42248600-42248800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr19:42248800-42249000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr19:42248800-42249400	Enhancers	Small Intestine	intestine
30	chr19:42249000-42249200	Flanking Active TSS	Primary hematopoietic stem cells	blood
31	chr19:42249000-42249200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr19:42249000-42250600	Enhancers	Colonic Mucosa	Colon
33	chr19:42249000-42251200	Enhancers	Stomach Mucosa	stomach
34	chr19:42249200-42249400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
35	chr19:42249200-42249600	Enhancers	Primary hematopoietic stem cells	blood
36	chr19:42249200-42250000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr19:42249400-42251000	Enhancers	Rectal Mucosa Donor 29	rectum
38	chr19:42249600-42249800	Flanking Active TSS	Primary B cells from cord blood	blood
39	chr19:42249600-42249800	Enhancers	Duodenum Mucosa	Duodenum
40	chr19:42249600-42250400	Flanking Active TSS	Primary hematopoietic stem cells	blood
41	chr19:42249800-42250000	Enhancers	Primary B cells from cord blood	blood
42	chr19:42249800-42250200	Weak transcription	Duodenum Mucosa	Duodenum
43	chr19:42250000-42250200	Bivalent Enhancer	Primary B cells from cord blood	blood
44	chr19:42250000-42250200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr19:42250200-42250400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr19:42250200-42250400	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
47	chr19:42250200-42250400	Enhancers	Small Intestine	intestine
48	chr19:42250200-42250600	Flanking Bivalent TSS/Enh	Primary B cells from cord blood	blood
49	chr19:42250200-42250800	Enhancers	Duodenum Mucosa	Duodenum
50	chr19:42250400-42250600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links